D Drummond
Internal Medicine · Hammond, LANPI 1801896360
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 134 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by AbbVie at 25.6% of the total.
Across 134 payments — averaging $18.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$617
- Johnson & Johnson$373
- Amgen$204
- GSK$128
- Stryker$126
- Boston Scientific$111
- plus $855 from 25 others
What the payments were for
- Food & beverage$2,414100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 50 | $617 |
| Johnson & Johnson | 14 | $373 |
| Amgen | 12 | $204 |
| GSK | 8 | $128 |
| Stryker | 2 | $126 |
| Boston Scientific | 2 | $111 |
| ALON Medical Technology | 1 | $97 |
| Teva Pharmaceuticals USA, Inc. | 5 | $86 |
| Abbott | 3 | $62 |
| Ironwood Pharmaceuticals, Inc | 4 | $55 |
| Eisai Inc. | 2 | $46 |
| Novo Nordisk | 3 | $43 |
| Jazz Pharmaceuticals Inc. | 2 | $38 |
| Kerecis Limited | 1 | $35 |
| Smith+Nephew | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Scpharmaceuticals Inc. | 2 | $32 |
| Amarin Pharma, Inc. | 2 | $30 |
| Sunovion Pharmaceuticals Inc. | 2 | $29 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Daiichi Sankyo Inc. | 2 | $28 |
| Biogen | 1 | $19 |
| Medtronic | 1 | $19 |
| Globus Medical | 1 | $18 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
| Radius Health, Inc. | 1 | $15 |
| Novartis | 1 | $13 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
| Apria Healthcare LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,414 in reported general payments places this provider in the 75th percentile of 1,528 internal medicine providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $6,384 |
| MyrbetriqMirabegron | 16 | $4,990 |
| Levothyroxine Sodium | 52 | $626 |
| Pantoprazole Sodium | 40 | $555 |
| Memantine Hcl | 16 | $481 |
| Rosuvastatin Calcium | 18 | $457 |
| Metformin Hcl | 29 | $442 |
| Atorvastatin Calcium | 23 | $377 |
| Humulin N KwikpenInsulin Nph Human Isophane | 11 | $375 |
| Amlodipine Besylate | 33 | $362 |
| Donepezil Hcl | 29 | $354 |
| Metoprolol Succinate | 19 | $345 |
| Potassium Chloride | 19 | $318 |
| Finasteride | 14 | $311 |
| Nabumetone | 13 | $303 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Hammond
- Anthony ZerangueHammond$20K
- Donna RyanBaton Rouge$991K
- Steven DeitelzweigNew Orleans$939K
- Bruce SamuelsCovington$200K
- Amanda FontenotMarrero$142K
- John SchwabBaton Rouge$122K
- Daniel EnglertNew Orleans$74K
- Everett BrownGretna$71K
- Rajan KhannaShreveport$54K
- Samuel StaggEunice$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.